Logo image of NYXH.BR

NYXOAH SA (NYXH.BR) Stock Price, Quote, News and Overview

EBR:NYXH - Euronext Brussels - BE0974358906 - Common Stock - Currency: EUR

5.64  +0.18 (+3.3%)

NYXH.BR Quote, Performance and Key Statistics

NYXOAH SA

EBR:NYXH (5/5/2025, 4:50:54 PM)

5.64

+0.18 (+3.3%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High11.4
52 Week Low5.04
Market Cap211.11M
Shares37.43M
Float23.09M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-13 2025-05-13
IPO09-18 2020-09-18


NYXH.BR short term performance overview.The bars show the price performance of NYXH.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

NYXH.BR long term performance overview.The bars show the price performance of NYXH.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of NYXH.BR is 5.64 EUR. In the past month the price decreased by -5.05%. In the past year, price decreased by -30.71%.

NYXOAH SA / NYXH Daily stock chart

NYXH.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 27.57 201.32B
IUI1.DE INTUITIVE SURGICAL INC 68.78 166.16B
BSX.DE BOSTON SCIENTIFIC CORP 38.66 136.07B
2M6.DE MEDTRONIC PLC 15.76 95.22B
SHL.DE SIEMENS HEALTHINEERS AG 21.32 54.12B
BOX.DE BECTON DICKINSON AND CO 11.84 42.21B
EWL.DE EDWARDS LIFESCIENCES CORP 29.17 39.27B
DC4.DE DEXCOM INC 49.09 27.91B
PHI1.DE KONINKLIJKE PHILIPS NV 16.34 21.35B
PHIA.AS KONINKLIJKE PHILIPS NV 16.22 21.19B
1PHIA.MI KONINKLIJKE PHILIPS NV 16.09 21.02B
BIM.PA BIOMERIEUX 30.62 13.99B

About NYXH.BR

Company Profile

NYXH logo image Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Company Info

NYXOAH SA

Rue Edouard Belin 12

Mont-Saint-Guibert BRABANT-WALLON BE

Employees: 147

NYXH Company Website

NYXH Investor Relations

Phone: 3226121755

NYXOAH SA / NYXH.BR FAQ

What is the stock price of NYXOAH SA today?

The current stock price of NYXH.BR is 5.64 EUR. The price increased by 3.3% in the last trading session.


What is the ticker symbol for NYXOAH SA stock?

The exchange symbol of NYXOAH SA is NYXH and it is listed on the Euronext Brussels exchange.


On which exchange is NYXH.BR stock listed?

NYXH.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for NYXOAH SA stock?

14 analysts have analysed NYXH.BR and the average price target is 12.83 EUR. This implies a price increase of 127.42% is expected in the next year compared to the current price of 5.64. Check the NYXOAH SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NYXOAH SA worth?

NYXOAH SA (NYXH.BR) has a market capitalization of 211.11M EUR. This makes NYXH.BR a Micro Cap stock.


How many employees does NYXOAH SA have?

NYXOAH SA (NYXH.BR) currently has 147 employees.


What are the support and resistance levels for NYXOAH SA (NYXH.BR) stock?

NYXOAH SA (NYXH.BR) has a support level at 5.37 and a resistance level at 5.65. Check the full technical report for a detailed analysis of NYXH.BR support and resistance levels.


Is NYXOAH SA (NYXH.BR) expected to grow?

The Revenue of NYXOAH SA (NYXH.BR) is expected to grow by 274.69% in the next year. Check the estimates tab for more information on the NYXH.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NYXOAH SA (NYXH.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NYXOAH SA (NYXH.BR) stock pay dividends?

NYXH.BR does not pay a dividend.


When does NYXOAH SA (NYXH.BR) report earnings?

NYXOAH SA (NYXH.BR) will report earnings on 2025-05-13.


What is the Price/Earnings (PE) ratio of NYXOAH SA (NYXH.BR)?

NYXOAH SA (NYXH.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.8).


NYXH.BR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NYXH.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NYXH.BR. NYXH.BR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NYXH.BR Financial Highlights

Over the last trailing twelve months NYXH.BR reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS decreased by -16.03% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -37.4%
ROE -52.3%
Debt/Equity 0.19
Chartmill High Growth Momentum
EPS Q2Q%-21.84%
Sales Q2Q%-30.76%
EPS 1Y (TTM)-16.03%
Revenue 1Y (TTM)3.98%

NYXH.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to NYXH.BR. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of -3.82% and a revenue growth 274.69% for NYXH.BR


Ownership
Inst Owners32.66%
Ins Owners20.26%
Short Float %N/A
Short RatioN/A
Analysts
Analysts81.43
Price Target12.83 (127.48%)
EPS Next Y-3.82%
Revenue Next Year274.69%